Systemic treatment for hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is one of the most common cancers with high mortality worldwide. Treatment options for patients with advanced stage HCC remain a great challenge. However, novel agents especially small molecule tyrosine kinase inhibitor and innovative immunotherapy demonstrate new prom...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-09-01
|
Series: | Chronic Diseases and Translational Medicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2095882X18300471 |